European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’). Luxembourg: Publications Office of the European Union.
| Preview | Title | Contact |
|---|---|---|
|
PDF (EMCDDA–Europol Joint Report on ‘MT-45’)
358kB |
In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on MT-45 as stipulated by Article 5.1 of the Council Decision.
Table of contents:
• Introduction
• Information collection process
• Information required by Article 5.2 of the Council Decision
• Information from the EMA (Article 5.3 of the Council Decision)
• Conclusion
• References
• Annexes
B Substances > New (novel) psychoactive substances > Synthetic opioids
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment
L Social psychology and related concepts > Legal availability or accessibility
VA Geographic area > Europe
Repository Staff Only: item control page